Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous system
Author:
Affiliation:
1. Department of Neurology, Medical Faculty; Heinrich-Heine-University; Düsseldorf Germany
Publisher
Wiley
Subject
Clinical Neurology,General Neuroscience
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jns.12169/fullpdf
Reference12 articles.
1. Potential therapeutic mechanism of K(+) channel block for MS;Baker;Mult Scler Relat Disord,2013
2. Failure of 3,4-Diaminopyridine to reverse conduction block in inflammatory neuropathies;Bergin;Ann Neurol,1993
3. A phase 3 trial of extended release oral dalfampridine in multiple sclerosis;Goodman;Ann Neurol,2010
4. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial;Goodman;Lancet,2009
5. Chronic inflammatory demyelinating polyradiculoneuropathy;Hughes;J Clin Immunol,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical, Neurophysiological, and MRI Markers of Fampridine Responsiveness in Multiple Sclerosis—An Explorative Study;Frontiers in Neurology;2021-10-26
2. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision;Journal of the Peripheral Nervous System;2021-07-30
3. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision;European Journal of Neurology;2021-07-30
4. Aminopiridines in the treatment of multiple sclerosis and other neurological disorders;Neurodegenerative Disease Management;2020-12
5. 4-Aminopyridine ameliorates relapsing remitting experimental autoimmune encephalomyelitis in SJL/J mice;Journal of Neuroimmunology;2018-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3